References
- 1. Sali M, Clarizio S, Pusceddu C, Zumbo A, Pecorini G, Rocca S, et al. Evaluation of the anti-tuberculosis activity generated by different multigene DNA vaccine constructs. Microbes and Infection. 2008; 10:605-12.10.1016/j.micinf.2008.02.012
- 2. Maher D, Dye C, Floyd K, Pantoja A, Lonnroth K, Reid A, et al. Planning to improve global health: the next decade of tuberculosis control. Bull World Health Organ. 2007; 85:341-7.10.2471/BLT.06.037820
- 3. Long EF, Viadya NK, Brandeau ML. Controlling Co-Epidemics: Analysis of HIV and Tuberculosis Infection Dynamics. Oper Res. 2008; 42:123-5.
- 4. Golub JE, Durovni B, King BS, Cavalacante SC, Pacheco AG, Moulton LH, et al. Recurrent tuberculosis in HIV-infected patients in Rio de Janeiro, Brazil AIDS. 2008; 22:2527-33.10.1097/QAD.0b013e328311ac4e
- 5. Endo Y, Takahashi M and Fujita T. Lectin complement system and pattern recognition. Immunobiology. 2006; 211:283-93.
- 6. Zhang XL and Ali MA. Ficolins: structure, function and associated diseases. Adv Exp Med Biol. 2008; 632: 105-15.
- 7. Harumiya S, Takeda K, Sugiura T, Fukumoto Y, Tachikawa H, Miyazono K, et al. Characterization of ficolins as novel elastin-binding proteins and molecular cloning of human ficolin-1. J Biochem. 1996; 120: 745-51.
- 8. Ichijo H, Hellman U, Wernstedt C, Gonez LJ, Claesson- Welsh L, Heldin CH et al. Molecular cloning and characterization of ficolin, a multimeric protein with fibrinogen- and collagen-like domains. J Biol Chem. 1993; 268:14505-13.
- 9. Takahashi M, Iwaki D, Kanno K, Ishida Y, Xiong J, Matsushita M, et al. Mannose-binding lectin (MBL)- associated serine protease (MASP)-1 contributes to activation of the lectin complement pathway. J Immunol. 2008; 180:6132-8.
- 10. Garred P, Honoré C, Ma YJ, Munthe-Fog L, Hummelshoj T. MBL2, FCN1, FCN2 and FCN3-The genes behind the initiation of the lectin pathway of complement. Mol Immunol. 2009; 46: 2737-44.10.1016/j.molimm.2009.05.005
- 11. Frankenberger M, Schwaeble W, Ziegler-Heitbrock L. Expression of M-Ficolin in human monocytes and macrophages. Mol Immunol. 2008; 45:1424-30.10.1016/j.molimm.2007.08.014
- 12. Liu Y, Endo Y, Iwaki D, Nakata M, Matsushita M, Wada I, et al. Human M-ficolin is a secretory protein that activates the lectin complement pathway. J Immunol. 2005; 175:3150-6.
- 13. Frederiksen PD, Thiel S, Larsen CB, Jensenius JC. Mficolin, an innate immune defence molecule, binds patterns of acetyl groups and activates complement. Scand J Immunol. 2005; 62:462-73.10.1111/j.1365-3083.2005.01685.x
- 14. Wittenborn T, Thiel S, Jensen L, Nielsen HJ, Jensenius JC.Characteristics and biological variations of M-ficolin, a pattern recognition molecule, in plasma. J Innate Immun. 2010; 2:167-80.10.1159/000218324
- 15. Schlapbach LJ, Kessler U, Thiel S, Hansen AG, Nelle M, Ammann RA, et al. M-ficolin in the neonatal period: Associations with need for mechanical ventilation and mortality in premature infants with necrotising enterocolitis. Mol Immunol. 2009; 46:2597-603.10.1016/j.molimm.2009.05.003
- 16. Matsushita M, Kuraya M, Hamasaki N, Tsujimura M, Shiraki H, Fujita T. Activation of the lectin complement pathway by H-ficolin (Hakata antigen). J Immunol. 2002; 168: 3502-6.10.4049/jimmunol.168.7.3502
- 17. Fujita T, Matsushita M, Endo Y.The lectin-complement pathway - its role in innate immunity and evolution. IMMUNOLOGICAL REVIEWS. 2004; 198: 185-202
- 18. Garlatti V, Belloy N, Martin L, Lacroix M, Matsushita M, Endo Y, et al. Structural insights into the innate immune recognition specificities of L- and H-ficolins. EMBO J. 2007; 26:623-33.10.1038/sj.emboj.7601500
- 19. Holmskov U, Thiel S, Jensenius JC .Collectins and ficolins: Humoral lectins of the innate immune defense. ANNUAL REVIEW OF IMMUNOLOGY. 2003; 21: 547-57810.1146/annurev.immunol.21.120601.140954
- 20. Sørensen R, Thiel S, Jensenius JC. Mannan-bindinglectin- associated serine proteases, characteristics and disease associations. Springer Semin Immunopathol. 2005; 27:299-319.10.1007/s00281-005-0006-z
- 21. Zundel S, Cseh S, Lacroix M, DahI MR, Matsushita M, Andriru JP, et al. Characterization of recombinant mannan-binding lectin-associated serine protease (MASP)-3 suggests an activation mechanism different from that of MASP-1 and MASP-2. J Immunol. 2004; 172:4342-50.
- 22. Kogawa K, Nagafuchi S, Katsuta H, Kudoh J, Tamiya S, Sakai Y, et al. Expression of AIRE gene in peripheral monocyte/dendritic cell lineage. Immunol Lett. 2002; 80:195-8.10.1016/S0165-2478(01)00314-5
- 23. Small PM. Tuberculosis: a new vision for the 21st century. Kekkaku. 2009; 84:721-6.
- 24. Ho P, Zhang L, Wei X, Seah GT. Mycobacterium chelonae sensitisation induces CD4(+)-mediated cytotoxicity against BCG. Eur J Immunol. 2009; 39: 1841-9.10.1002/eji.200838933
- 25. Mathurin KS, Martens GW, Kornfeld H, Welsh RM. CD4 T-cell-mediated heterologous immunity between mycobacteria and poxviruses. J Virol. 2009; 83: 3528-39.10.1128/JVI.02393-08
- 26. Wang QL, Pan Q, Ma YF, Wang K, Sun P, Liu SW, et al. An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis. Vaccine. 2009; 27:6712-22.10.1016/j.vaccine.2009.08.096
- 27. Lazarevic V, Flynn J. CD8+ T cells in tuberculosis. Am J Respir Crit Care Med. 2002; 166:1116-21.
- 28. Weichold FF, Mueller S, Kortsik C, Hitzler WE, Wulf MJ, Hone DM, et al. Impact of MHC class I alleles on the M. tuberculosis antigen-specific CD8+ T-cell response in patients with pulmonary tuberculosis. Genes Immun. 2007; 8:334-43.10.1038/sj.gene.6364392
- 29. Jo EK. Mycobacterial interaction with innate receptors: TLRs, C-type lectins, and NLRs. Curr Opin Infect Dis. 2008; 21:279-86.10.1097/QCO.0b013e3282f88b5d
- 30. Liu PT, Modlin RL. Human macrophage host defense against Mycobacterium tuberculosis. Curr Opin Immunol. 2008; 20:371-6.10.1016/j.coi.2008.05.014
- 31. Ip WK, Takahashi K, Ezekowitz RA, Stuart LM. Mannose-binding lectin and innate immunity. Immunol Rev. 2009; 230:9-21.
- 32. Thiel S. Complement activating soluble pattern recognition molecules with collagen-like regions, mannan-binding lectin, ficolins and associated proteins. Mol Immunol. 2007; 44:3875-88.10.1016/j.molimm.2007.06.005
- 33. Beinrohr L, Dob ó J, Závodszky P, Gal P. C1, MBLMASPs and C1-inhibitor: novel approaches for targeting complement-mediated inflammation. Trends Mol Med. 2008; 14:511-21.10.1016/j.molmed.2008.09.009
- 34. Lynch NJ, Roscher S, Hartung T, Morath S, Matsushita M, et al. L-ficolin specifically binds to lipoteichoic acid, a cell wall constituent of Gram-positive bacteria, and activates the lectin pathway of complement. J Immunol. 2004; 172:1198-202.
- 35. Nahid AM, Sugii S. Binding of porcine ficolin-alpha to lipopolysaccharides from Gram-negative bacteria and lipoteichoic acids from Gram-positive bacteria. Dev Comp Immunol. 2006; 30:335-43.10.1016/j.dci.2005.04.002
- 36. Hummelshoj T, Fog LM, Madsen HO, Sim RB, Garred P. Comparative study of the human ficolins reveals unique features of Ficolin-3 (Hakata antigen). Mol Immunol. 2008; 45:1623-32.